Go to
JCI Insight
Laurie Glimcher
Laurie Glimcher is a world-class immunologist who discovered the master transcription factors that direct immune cells to commit and activate. She has also discovered a key anabolic bone pathway and become an expert on ER stress and lipoprotein production. Most recently, Glimcher discovered a critical signaling pathway in both tumor cells and host immune responses. All the while, she’s acted as an academic leader, at Harvard School of Public Health and as dean of Weill Cornell Medical School, and she is about to take the reins of the Dana-Farber Cancer Institute as President and CEO.
Published July 1, 2016, by Ushma S. Neill
Related articles
Follow JCI:
Copyright © 2020 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)
Copyright © 2020 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)